Trump drug prices News

Trump Administration Halts Plan to Sideline Pharmacy Benefit Managers

The White House abandoned a push to end rebates paid to middlemen who negotiate drug prices on behalf of health insurers, a move that could turn scrutiny back on how drugmakers themselves set prices. President Donald Trump has made lowering …

Court Halts Trump Plan to Require Drug Prices in TV Ads

A federal judge on Monday dealt a blow to the Trump administration by striking down a new rule that would have forced pharmaceutical companies to include the wholesale prices of their drugs in television advertising. U.S. District Judge Amit Mehta …

Drugmakers Sue to Halt Rule on Prices in TV Ads

U.S. drugmakers on Friday filed a lawsuit to prevent the companies from disclosing the list price of prescription drugs in direct-to-consumer television advertisements as per a newly proposed government regulation. The lawsuit was jointly filed by Amgen Inc, Merck & …

U.S. to Require Drug Companies to Disclose List Prices in TV Ads

The Trump administration on Wednesday said it will require drug makers to disclose the list price of prescription drugs in direct-to-consumer television advertisements, part of the government’s efforts to lower costs for U.S. consumers. The list price would be included …

Trump Eyes Bipartisan Deals on Infrastructure and Drug Prices

U.S. President Donald Trump is willing to work with congressional Democrats to lower drug prices for Americans and on infrastructure funding, White House adviser Kellyanne Conway said on Tuesday. Conway said the Trump administration considered those two issues as areas …

Trump Plan to Curb Drug Prices Targets Rebates to Pharmacy Benefit Managers

The Trump administration proposed ending a complex system of drug rebates that influence tens of billions of dollars in U.S. pharmaceutical spending, a move that could upend the relationship between drugmakers and pharmacy benefits middlemen. The proposal, a long-awaited part …

Trump’s FTC Appointee Eyes Task Force to Investigate Drug Prices

President Donald Trump’s nominee to lead the Federal Trade Commission said he’s “very concerned” about price increases for prescription drugs and will explore forming a task force to monitor whether higher prices are due to anti-competitive conduct. Joe Simons, a …